Literature DB >> 34855096

The role of anticoagulation for superior sagittal sinus thrombosis following craniotomy for resection of parasagittal/parafalcine meningiomas.

Adrian E Jimenez1, Adham M Khalafallah2, David Botros1, Melanie A Horowitz1, Omar Azmeh1, Shravika Lam3, Leonardo A P Oliveira1, Sachiv Chakravarti1, Sophie Liu1, Esther Wu1, Oren Wei1, Jose L Porras1, Chetan Bettegowda1, Rafael J Tamargo1, Henry Brem1, Debraj Mukherjee4.   

Abstract

OBJECTIVE: The safety and efficacy of anticoagulation in managing superior sagittal sinus (SSS) thrombosis remains unclear. The present study investigated the relationship between anticoagulation and cerebrovascular complications in parasagittal/parafalcine meningioma patients presenting with post-surgical SSS thrombosis.
METHODS: We analyzed 266 patients treated at a single institution between 2005 and 2020. Bivariate analysis was conducted using the Mann-Whitney U test and Fisher's exact test. Multivariate analysis was conducted using a logistic regression model. Blood thinning medications investigated included aspirin, warfarin, heparin, apixaban, rivaroxaban, and other novel oral anticoagulants (NOACs). A symptomatic SSS thrombosis was defined as a radiographically apparent thrombosis with new headaches, seizures, altered sensorium, or neurological deficits.
RESULTS: Our patient cohort was majority female (67.3%) with a mean age ([Formula: see text] SD) of 58.82 [Formula: see text] 13.04 years. A total of 15 (5.6%) patients developed postoperative SSS thrombosis and 5 (1.9%) were symptomatic; 2 (0.8%) symptomatic patients received anticoagulation. None of these 15 patients developed cerebrovascular complications following observation or anticoagulative treatment of asymptomatic SSS thrombosis. While incidence of any other postoperative complications was significantly associated with SSS thrombosis in bivariate analysis (p = 0.015), this association was no longer observed in multivariate analysis (OR = 2.15, p = 0.16) when controlling for patient age, sex, and anatomical location of the tumor along the SSS.
CONCLUSIONS: Our single-institution study examining the incidence of SSS thrombosis and associated risk factors highlights the need for further research efforts better prognosticate this adverse outcome. Conservative management may represent a viable treatment strategy for patients with SSS thrombosis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticoagulation; Meningioma; Neuro-oncology; Outcomes; Thrombosis

Mesh:

Substances:

Year:  2021        PMID: 34855096     DOI: 10.1007/s11060-021-03916-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  4 in total

Review 1.  A review of therapeutic strategies for the management of cerebral venous sinus thrombosis.

Authors:  Ricky Medel; Stephen J Monteith; R Webster Crowley; Aaron S Dumont
Journal:  Neurosurg Focus       Date:  2009-11       Impact factor: 4.047

2.  Quantifying the utility of a multidisciplinary neuro-oncology tumor board.

Authors:  Adham M Khalafallah; Adrian E Jimenez; Carlos G Romo; David Olayinka Kamson; Lawrence Kleinberg; Jon Weingart; Henry Brem; Stuart A Grossman; Debraj Mukherjee
Journal:  J Neurosurg       Date:  2020-09-18       Impact factor: 5.115

Review 3.  Anticoagulation for cerebral sinus thrombosis.

Authors:  J Stam; S F De Bruijn; G DeVeber
Journal:  Cochrane Database Syst Rev       Date:  2002

4.  Dural Venous Sinus Thrombosis after Vestibular Schwannoma Surgery: The Anticoagulation Dilemma.

Authors:  Bledi C Brahimaj; Andre Beer-Furlan; Fred Crawford; Ravi Nunna; Matthew Urban; Gary Wu; Eric Abello; Vikrant Chauhan; Mehmet Kocak; Lorenzo Muñoz; Richard M Wiet; Richard W Byrne
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.